FLGT - Could Fulgent Genetics Be a Millionaire-Maker Stock?
Over the past year, shares of Fulgent Genetics (NASDAQ: FLGT) have skyrocketed over 970%, reaching an all-time high of $189.89 on Feb. 7. Since then, however, the COVID-19 test manufacturer has seen its stock price plunge by almost 35%. What could possibly be behind such wild trading action?
As it turns out, many investors are starting to see Fulgent Genetics as a one-time fad that got rich in 2020 for doing its part in fighting the coronavirus pandemic, and is about to fall back to reality as the risks posed by the virus subside. Can investors count on the biotech to continue delivering multibagger returns, or is Fulgent Genetics' growth story over?
Image source: Getty Images.
For further details see:
Could Fulgent Genetics Be a Millionaire-Maker Stock?